Article
FANCF methylation contributes to chemoselectivity in ovarian cancer.
Cancer cell - 1 May 2003
Olopade Olufunmilayo I, Wei Minjie
Abstract excerpt
A new model of ovarian cancer tumor progression implicates aberrant FANCF promoter methylation that is associated with gene silencing and disruption of the Fanconi-anemia-BRCA pathway. Disruption of the pathway occurs de novo in ovarian cancers and may contribute to selective sensitivity to platinum salts.
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
